Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

CCR5 serves as a requisite fusion coreceptor for clinically relevant strains of human immunodeficiency virus type 1 (HIV-1) and provides a promising target for antiviral therapy. However, no study to date has examined whether monoclonal antibodies, small molecules, or other nonchemokine agents posse...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Trkola, Alexandra, Ketas, Thomas J., Nagashima, Kirsten A., Zhao, Lu, Cilliers, Tonie, Morris, Lynn, Moore, John P., Maddon, Paul J., Olson, William C.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2001
Matèries:	Virus-Cell Interactions
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC113953/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11134270/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.2.579-588.2001
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!